[Form 4] LeMaitre Vascular, Inc. Insider Trading Activity

Rhea-AI Filing Summary

John A. Roush, a director of LeMaitre Vascular (LMAT), exercised stock options to acquire 7,500 common shares at an exercise price of $37.29 on 08/08/2025 and 08/11/2025, as reported in Table II. The form states these option exercises converted derivative holdings into common stock.

Roush also sold a total of 7,500 shares across transactions on 08/08/2025 and 08/11/2025 at reported weighted-average prices of $93.4872, $92.783 and $91.8181, with execution ranges between $91.38 and $94.00. Following these transactions, the reporting person beneficially owned 2,916 shares of LeMaitre Vascular.

Positive

• Exercised options to acquire 7,500 common shares at an exercise price of $37.29
• Transaction details include weighted-average sale prices and execution ranges, enabling quantification of proceeds
• Ending beneficial ownership clearly reported as 2,916 shares

Negative

• Reported sales of 7,500 shares by the reporting person on 08/08/2025 and 08/11/2025
• Sales executed at weighted-average prices between $91.8181 and $93.4872, reducing direct holdings to 2,916 shares

Insights

Corporate Governance Expert

TL;DR: Director exercised options and sold the resulting shares, ending with 2,916 shares beneficially owned.

The filing documents option exercises totaling 7,500 shares at a $37.29 exercise price and contemporaneous sales of 7,500 shares at weighted-average prices reported between $91.8181 and $93.4872. These transactions are routine equity plan-related activities documented on Form 4 and do not, on their face, indicate a change in control or a material corporate event. The reported exercise and sale quantities and prices are sufficient for investors to quantify insider liquidity and remaining direct ownership of 2,916 shares.

Securities Analyst

TL;DR: Insider exercised options and sold shares; net reporting position is 2,916 shares, with executed sale prices in the low $90s.

The report shows option exercises on 08/08/2025 and 08/11/2025 that converted derivative securities into common stock and immediate sales recorded the same days. The filing discloses weighted-average sale prices and execution ranges ($91.38–$94.00), providing clear data to estimate gross proceeds and remaining insider stake. Without outstanding share count or company-level context in this filing, the impact on capitalization and float cannot be determined from this document alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roush John A

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, 63 SECOND AVENUE

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/08/2025		M		939(1)	A	$37.29	3,855	D
Common Stock	08/08/2025		S		939	D	$93.4872(2)	2,916	D
Common Stock	08/11/2025		M		6,561(1)	A	$37.29	9,477	D
Common Stock	08/11/2025		S		4,987	D	$92.783(3)	4,490	D
Common Stock	08/11/2025		S		1,574	D	$91.8181(4)	2,916	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$37.29	08/08/2025		M			939	12/02/2020(5)	12/02/2025	Common Stock	939	$0	6,561	D
Stock Option (Right to Buy)	$37.29	08/11/2025		M			6,561	12/02/2020(5)	12/02/2025	Common Stock	6,561	$0	0	D

Explanation of Responses:

1. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

2. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $93.025 to $94.00. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

3. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $92.21 to $93.20. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

4. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $91.38 to $92.14. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.

5. This option is fully vested and exercisable.

	/s/ Nathan Ulrich	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did John A. Roush report for LMAT?

John A. Roush reported exercising 7,500 options at $37.29 and selling 7,500 shares on 08/08/2025 and 08/11/2025.

How many shares does the reporting person own after the transactions (LMAT)?

The filing reports a beneficial ownership of 2,916 shares following the reported transactions.

At what prices were the shares sold in the Form 4 for LMAT?

Weighted-average sale prices reported: $93.4872, $92.783 and $91.8181; execution ranges noted between $91.38 and $94.00.

What was the exercise price of the options exercised by the reporting person (LMAT)?

The options were exercised at an exercise price of $37.29 per share.

Do the Form 4 entries show derivative securities were converted to common stock?

Yes. Table II lists stock options exercised on 08/08/2025 and 08/11/2025 that resulted in common shares reported in Table I.